Become a pioneer in the world of AI-driven trading with Tickeron's advanced technology, elevating your decision-making process.
In the world of trading, the ability to predict market trends is invaluable. Our AI has identified a bearish trend for Walgreens Boots Alliance (WBA, $29.07), predicting a decline of 4% to $27.91 or more within the next month. Based on similar scenarios where the stock trended down during the month, the odds of a downtrend continuation are 72%.
Walgreens Boots Alliance operates within the drugstore chains industry, which includes stores that sell both prescription and non-prescription medicines, health, beauty, and personal care products. Many pharmacy retail chains have launched their own pharmacy benefits management services over time. Given that the demand for medical products is typically less sensitive to economic cycles, the drugstore retail chains industry can be largely considered as non-cyclical. Some of the biggest operators in this industry include CVS Health Corporation, Walgreens Boots Alliance Inc., and Rite Aid Corporation.
In terms of market capitalization, the average across the Drugstore Chains Industry is 3.04B, with a range from 3.29K to 24.72B. WBA holds the highest valuation in this group at 24.72B, while RLLVF is at the lower end with 3.29K.
Looking at price growth, the average weekly growth across all stocks in the Drugstore Chains Industry was 1%, with a monthly growth of 5%, and a quarterly decline of -3%. MEDS experienced the highest price growth at 94%, while RAD experienced the biggest fall at -24%.
In terms of volume, the average weekly volume growth across all stocks in the industry was 53%, with a monthly volume growth of 109% and a quarterly volume growth of 173%.
In conclusion, our AI's prediction of a bearish trend for Walgreens Boots Alliance underscores the power of AI in predicting market trends. As we continue to refine our AI algorithms, we look forward to sharing more insights and predictions with you. Stay tuned!
Are you ready to embrace the future of trading? Tickeron's AI robots empower investors to make smarter decisions.
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day RSI Indicator for WBA moved out of overbought territory on July 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
WBA broke above its upper Bollinger Band on June 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on WBA as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for WBA just turned positive on June 30, 2025. Looking at past instances where WBA's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WBA advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 117 cases where WBA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.250) is normal, around the industry mean (3.463). P/E Ratio (32.848) is within average values for comparable stocks, (181.246). Projected Growth (PEG Ratio) (2.170) is also within normal values, averaging (1.915). Dividend Yield (0.086) settles around the average of (0.050) among similar stocks. P/S Ratio (0.117) is also within normal values, averaging (0.903).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. WBA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WBA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of drug store services
Industry DrugstoreChains